InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2022 Financial Report, Corporate Update
August 15, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting on its financial results for the second quarter 2022; the company also released a corporate and commercial update. Highlights of the report include revenue for the quarter, which totaled 6.2 million, a 17.5% increase from Q2 2021, which was $5.3 million, with […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research at Conference Showing Support for Rural Areas
August 12, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has presented results from its recent research showing impact of DRIO solutions to support people living in rural areas by delivering lasting health improvements. According to the presentation, the research focused on Dario’s ability to improve the health of members in rural areas, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Solution to Drive Digital, Seamless Experience for National Health Plan
August 11, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a national health plan selected its solution to drive self-service across its mental wellbeing care resources. According to the update, Dario’s behavioral health solution will become part of the plan’s platform to increase access to navigation, self-help and coaching. “We […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q2 Earnings Results
August 10, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will release its financial results for Q2 2022, the period ended June 30, 2022, next week. The report will be issued on Monday, Aug. 15, 2022. In addition, the company has scheduled a conference call and webcast to discuss the report. That call […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Present Research Regarding Digital Solution on Depression, Anxiety at APA Convention
August 4, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is sharing the results of its studies on anxiety and depression at the American Psychological Association (“APA”) annual convention. The three-day convention begins today and runs through Aug. 6, 2022; it is being held virtually and in person in Minneapolis, Minnesota. According to […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs New Multi-Chronic Contract with National Employer for Full-Solution Suite
July 21, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked a new deal to provide its full suite of integrated chronic-condition management solutions to a national employer; this new contract outlines Dario’s commitment to support employees living with diabetes, high blood pressure, and needs related to weight, musculoskeletal pain and behavioral health. The new […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Contract with National Employer
June 21, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced a new contract to deliver its digital behavioral health solution for a leading provider of integrated technology solutions for financial professionals. According to the update, Dario expects to launch the new account in the third quarter of 2022. “Demand for digital […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with Solera Health for Added Hypertension Management Solutions
June 16, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is partnering with Solera Health to offer a world-class solution for treating hypertension. Solera Health is a premier platform for connecting people to proven, personalized health solutions, and this new partnership expands Solera’s suite of best-in-class digital and community evidence-based health solutions. The […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners with OrbiMed to Close on $50 Million Credit Facility
June 9, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has closed on a senior secured term loan facility of up to $50 million with OrbiMed. According to the announcement, the investment from the elite healthcare fund indicates validation and the company’s access to capital, thereby creating a pathway to execute on DRIO’s strategic operating […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presenting Key Findings from Three New Studies at ADA Scientific Sessions
June 3, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that company officials are presenting three new studies at the American Diabetes Association’s (“ADA”) 82nd Scientific Sessions; the sessions begin today and run through June 7, 2022, in New Orleans. According to the announcement, two of the studies demonstrated noticeable improvement in glucose […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters New Commercial Contracts as Market Develops Appreciation for Integrated Digital Solutions
May 19, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new contracts to provide digital therapeutics solutions to a national employer and a provider, both of which are expected to begin enrolling members in the third quarter of 2022. “Dario continues to build a strong client base across its suite […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Record Quarterly Revenues in Q1 2022
May 12, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today reported financial results for the first quarter 2022 and provided a corporate and commercial update. “Our first quarter results reflect our increasingly successful transition to a B2B model with growing revenue and gross margins,” said Dario’s Chief Executive Officer Erez Raphael. “We […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q1 2022 Results, Conference Call
May 4, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced it would release its financial results for the first quarter ended March 31, 2022, on Thursday, May 12, 2022. On the same day, the company will host a conference call and webcast at 8:30 am Eastern Time. DRIO’s Chief Executive Officer […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Presents Research Supporting ‘Digital Solutions That Prioritize a Whole Health Experience’
April 27, 2022
DarioHealth (NASDAQ: DRIO) today announced publication of a retrospective, real-world study demonstrating the impact of managing diabetes and weight together on a single digital platform at the Advanced Technologies and Treatments for Diabetes (“ATTD”) Conference being held April 27-30 in Barcelona and online. “I am proud to share new evidence that Dario’s approach to providing […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Provide Digital Solutions for Health Plan Colorado Access
April 14, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced its entry into a new agreement with Colorado Access, the largest public sector health plan in the state of Colorado. Under the agreement, Dario will provide digital chronic condition management solutions for Colorado Access’ Medicaid population, beginning with thousands of its […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures Additional Employer Contracts
March 23, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new employer agreements, including one with a U.S.- based social platform employer and another with a global health care company. According to the update, the contracts are expected to launch in the second quarter of 2022. Rick Anderson, president and […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q4, Full-Year 2021 Financial Report, Operational Update
March 22, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has reported its financial numbers and corporate update for the fourth quarter and full year. The company noted that it had experienced a transformational year with strong revenue growth of 190% quarter-over-quarter and 171% full year-over-full year, along with adding 54 new accounts […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q4 and Full Year 2021 Results
March 14, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that it will release its financial results for the fourth quarter and full year ended Dec. 31, 2021, after the close of trading on Monday, March 21, 2022. In addition, the company’s CEO Erez Raphael, president and general manager of North […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds Two New Contracts to Growing Number of Clients
March 9, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has signed two new contracts in the employer and provider markets; these new contracts serve as indicators of the company’s success in winning busiess in these sectors. The contracts, which are expected to begin in Q2 2022, will implement Dario’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Participate in Upcoming Cowen Healthcare Conference
March 7, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that management will participate in the Cowen 42nd Annual Healthcare Conference, which is slated to take place virtually on March 7-9, 2022. DarioHealth’s CEO Erez Raphael and president and general manager of North America Rick Anderson will participate in a fireside […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Direct Offering Pricing, Inks Agreement with Sanofi US
March 1, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, announced that it has entered into definitive agreements with institutional investors; those investors include Israel-based insurance companies. The registered direct offering includes the issuance of approximately 5,342,013 shares of DRIO common stock or common stock equivalents at a price of $7.49 per share. The company […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Publishes Learnings from Single DTx Platform Approach to Chronic Condition Management
February 9, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced the publication of a retrospective, real-world study demonstrating the impact of managing blood pressure and diabetes together on the same digital platform. The study, which showed a significant improvement in average blood glucose levels during the first six months of using […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Four New Employer Contracts, Clients Now Number 40+
February 8, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has entered new contracts agreeing to deliver its digital therapeutics solutions for four employers; the new accounts are slated to being during the first half of 2022. According to the company, its new clients include a northeast regional employer that contracted for Dario’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Move to Acquire Physimax Technologies
January 20, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced its entry into an agreement to purchase all of the right, title and interest in certain assets of Physimax Technologies Ltd. A leading provider of computer vision (“CV”) technology for musculoskeletal (“MSK”) functional screening and predictive risk of injury assessment, Physimax’s […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Inks Deal with Leading Regional Health Plan
January 19, 2022
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced that it has entered into an agreement with a larger regional health plan. The agreement calls for DRIO to provide its digital therapeutic solution for diabetes to eligible Medicaid members in and around the mid-Atlantic region. According to the announcement, the contract should […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Host Jan. 19 Investor Webinar on Navigating Emerging Digital Health Trends
January 18, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that it will host an investor webinar on navigating emerging digital health trends in 2022. Interested parties are invited to join DarioHealth’s management and two renowned industry experts at 8 a.m. ET on Wednesday, Jan. 19, to better understand how strong […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Secures New Contracts in the Employer Market
January 6, 2022
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced two new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. According to the update, the new clients include two Northeast regional employers, one in the finance industry set to deploy Dario’s full suite of […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Selected as Exclusive DTx Provider to Leading Benefits Brokerage
December 21, 2021
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, today announced a new strategic partnership with a leading employer benefits brokerage (the “partner”) to sell its digital therapeutic solutions for diabetes, hypertension and musculoskeletal health as part of a new premier employee health benefits product for small businesses. According to the update, […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Achieves Key Milestone to Secure More than 50 Signed Clients
December 2, 2021
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, today announced new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. According to the update, the new clients include a regional employer contract for behavioral health as well as a strategic partnership in the provider market […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds to Growing List of Employer Contracts
November 18, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has inked two additional contracts to provide its highly personalized digital therapeutic services; the contracts will be in effect beginning in 2022. Dario is now providing services to 49 clients multi chronic condition platform solutions, with demand continuing to grow. Dario offers its […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q3 Finance, Business Report
November 16, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, reported its third-quarter 2021 financial results and business update. Of note was DRIO’s strong business-to-business (“B2B”) new contract growth, with 47 signed accounts, an 85% increase achieved in the last two quarters, and the company’s pipeline continued strong growth to $1 billion, after […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Created New Position, Names New Chief Commercial Officer
November 15, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has created a new executive role — chief commercial officer — and appointed Jerrod Helms to that position. The role is designed to support the accelerating growth of Dario as a leader in the digital therapeutics market. Helms will focus on DRIO’s rapid expansion […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Adds to Growing Number of Contracts to Provide Proprietary Digital Therapeutic Solutions
November 11, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has signed contracts with two new employers and a new provider channel to provide digital therapeutic solutions; the services are set to begin Q1 2022. DRIO’s clients include contracts for behavioral health with a southwest regional employer in the healthcare industry and a […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Scheduled Release of Q3 2021 Results, Conference Call and Webcast
November 8, 2021
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics (“DTx”) market, today announced that the company will release financial results for the third quarter ended Sept. 30, 2021, after the close of trading on Monday, Nov. 15, 2021. In addition, DarioHealth’s CEO Erez Raphael, CFO Zvi Ben-David and president and general manager of North […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Management to Participate in November Investor Conferences
November 5, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, will be participating in two investor conferences in November. The company announced that CEO Erez Raphael will be part of a fireside chat at the 30th annual Credit Suisse Healthcare Conference. The event, scheduled for Nov. 9, 2021, features one-on-one investor meetings. Rapael’s fireside […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Joins Strategic Partnership with National Benefits Administrative Platform
November 3, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced its newest partnership. The company will be providing its full suite of digital therapeutics and health solutions to a leading national benefits administrative platform; the partnership will begin in January 2022. The company plans on offering integrated chronic condition solutions for […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Two New RPM Partnerships
November 1, 2021
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has inked two contracts to provide remote patient monitoring (“RPM”) services to prominent regional providers in Hawaii and Georgia. The Hawaii contract expands Dario’s provider footprint with one of the largest providers while the Georgia contract is with a metro Atlanta primary care system that […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Collaborates with Virgin Pulse to Expand Visibility of Next-Gen Digital Solutions
October 27, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital-therapeutics (“DTx”) market, today announced that it has partnered with Virgin Pulse, the leading global provider of digital and live health and wellbeing solutions. Under the collaboration, DarioHealth is making its next-generation digital therapeutic and health solutions available for contract through Virgin Pulse to employers and health […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Contract for Full Suite of Digital Therapeutic Solutions
October 25, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital-therapeutics (“DTx”) market, today announced its entry into a contract with a U.S. national employer for the company’s full suite of chronic condition management solutions, including diabetes, pre-diabetes, hypertension, musculoskeletal, behavioral health, and digital employee assistance programs. According to the update, enrollment of DarioHealth’s multi-condition suite of […]
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Unveils Innovative Digital Musculoskeletal Solution
October 18, 2021
DarioHealth (NASDAQ: DRIO), a leader in the global digital-therapeutics (“DTx”) market, today announced the launch of Dario Move, a new digital physical therapy solution to manage common musculoskeletal (“MSK”) conditions that drive significant costs for employers and health plans. The company is unveiling the solution at HLTH 2021, one of the largest and most important […]